Accelerating Cell Therapy for Stroke in Japan
Authors:
- Kiyohiro HoukinKHKiyohiro Houkin
- Hideo ShichinoheHSHideo Shichinohe
- Koji AbeKAKoji Abe
- Teruyo AratoTATeruyo Arato
- Mari DezawaMDMari Dezawa
- Osamu HonmouOHOsamu Honmou
- Nobutaka HorieNHNobutaka Horie
- Yasuo KatayamaYKYasuo Katayama
- Kohsuke KudoKKKohsuke Kudo
- Satoshi KurodaSKSatoshi Kuroda
- Tomohiro MatsuyamaTMTomohiro Matsuyama
- Ichiro MiyaiIMIchiro Miyai
- 1 April 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (4) , E145-+
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Regenerative medicine legislation in Japan for fast provision of cell therapy productsClinical Pharmacology & Therapeutics, 2015
- Accelerating Regulatory Science Initiatives for the Development of Drugs for Alzheimer’s Disease in JapanClinical Therapeutics, 2015
- Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke PatientsStem Cells and Development, 2015
- Stem Cells as an Emerging Paradigm in Stroke 3Stroke, 2014
- Stem Cell Therapy for Cerebral Ischemia: From Basic Science to Clinical ApplicationsJournal of Cerebral Blood Flow & Metabolism, 2012
- Therapeutic Impact of Human Bone Marrow Stromal Cells Expanded by Animal Serum–Free Medium for Cerebral Infarct in RatsNeurosurgery, 2011
- Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in strokeBrain, 2011
- Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) IIStroke, 2011
- S tem Cell T herapies as an E merging P aradigm in S troke (STEPS)Stroke, 2009
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006